CXCL2 — C-X-C Motif Chemokine Ligand 2
Introduction
CXCL2 (C-X-C Motif Chemokine Ligand 2), also known as MIP-2 (Macrophage Inflammatory Protein-2) or GRO-β (Growth-Regulated Oncogene Beta), is a small chemokine protein that plays critical roles in inflammation, immune cell recruitment, and neuroinflammation. Originally characterized as a neutrophil chemoattractant, CXCL2 has emerged as a key mediator in neurodegenerative disease processes[@raman2011].
...
CXCL2 — C-X-C Motif Chemokine Ligand 2
Introduction
CXCL2 (C-X-C Motif Chemokine Ligand 2), also known as MIP-2 (Macrophage Inflammatory Protein-2) or GRO-β (Growth-Regulated Oncogene Beta), is a small chemokine protein that plays critical roles in inflammation, immune cell recruitment, and neuroinflammation. Originally characterized as a neutrophil chemoattractant, CXCL2 has emerged as a key mediator in neurodegenerative disease processes[@raman2011].
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">CXCL2 Chemokine</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>CXCL2</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>MIP-2, GRO-β, GRO2</td></tr>
<tr><td><strong>Full Name</strong></td><td>C-X-C Motif Chemokine Ligand 2</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>4q21.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[2920](https://www.ncbi.nlm.nih.gov/gene/2920)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[139387](https://omim.org/entry/139387)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000024836</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P19875](https://www.uniprot.org/uniprot/P19875)</td></tr>
<tr><td><strong>Protein Size</strong></td><td>99 amino acids (mature: 72 aa)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">224 edges</a></td>
</tr>
</table>
</div>
Protein Structure and Function
Structural Features
CXCL2 belongs to the CXC chemokine family characterized by:
- N-terminal region: Contains the ELR motif (Glu-Leu-Arg) essential for receptor binding and angiogenic activity
- CXC motif: Conserved cysteine-cysteine arrangement
- C-terminal heparin-binding domain: Mediates interaction with extracellular matrix
Receptor Signaling
CXCL2 primarily signals through:
| Receptor | Expression | Function |
|----------|------------|----------|
| CXCR2 | Neutrophils, monocytes, microglia | Primary signaling receptor |
| CXCR1 | Neutrophils | Secondary receptor |
Signaling cascades:
G-protein coupled receptor activation
PI3K/AKT pathway activation
MAPK/ERK pathway activation
NF-κB pathway activationPhysiological Functions
Inflammation and Immune Response
Neutrophil Chemotaxis: Potent attractant for neutrophils, directing them to sites of infection or injury
Inflammatory Amplification: Amplifies inflammatory responses through positive feedback loops
Angiogenesis: Promotes neovascularization (ELR-dependent)
Wound Healing: Important for tissue repair and remodelingCellular Sources
| Cell Type | Condition | CXCL2 Expression |
|-----------|-----------|------------------|
| Neutrophils | Resting/Activated | Constitutive + inducible |
| Macrophages | LPS, TNF-α | Highly induced |
| Microglia | Pro-inflammatory cytokines | Inducible |
| Astrocytes | Injury, disease | Inducible |
| Fibroblasts | Various stresses | Inducible |
Role in Neurodegeneration
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), CXCL2 contributes to disease pathology:
Neuroinflammation: Elevated in AD brain regions, particularly around amyloid plaques
Microglial Activation: Recruits microglia to [amyloid-beta](/proteins/amyloid-beta) deposits
Neuronal Toxicity: Can contribute to excitotoxic neuronal death through microglial-mediated mechanisms
Disease Progression: Higher CXCL2 levels correlate with disease severityParkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
Dopaminergic Neuron Vulnerability: CXCL2 is elevated in the [substantia nigra](/brain-regions/substantia-nigra) of PD patients
Microglial Activation: Contributes to chronic neuroinflammation in dopaminergic pathways
α-Synuclein Response: Upregulated in response to [alpha-synuclein](/proteins/alpha-synuclein) aggregationAmyotrophic Lateral Sclerosis (ALS)
In [ALS](/diseases/amyotrophic-lateral-sclerosis)[@liu2016]:
Motor Neuron Injury: CXCL2 contributes to inflammatory death of motor neurons
Glial Activation: Activates astrocytes and microglia in spinal cord
Disease Progression: CSF and tissue levels correlate with disease progressionStroke and Brain Injury
Ischemic Stroke: Rapidly upregulated following cerebral ischemia
Traumatic Brain Injury: Contributes to secondary damage through inflammation
Blood-Brain Barrier Disruption: Increases BBB permeabilityMechanistic Pathway
Mermaid diagram (expand to render)
Expression Patterns
Brain Regional Distribution
- Hippocampus: Moderate expression, increased in disease
- Cortex: Present in all layers, higher in upper layers
- Substantia Nigra: Elevated in Parkinson's disease
- Spinal Cord: High in motor neuron regions (ALS)
Cellular Localization
- Neurons: Low basal, inducible expression
- Astrocytes: Major source in diseased states
- Microglia: Activated microglia are potent producers
- Endothelial Cells: Blood-brain barrier as source
Therapeutic Implications
Biomarker Potential
- CXCL2 levels in CSF may indicate neuroinflammatory activity
- Could serve as a biomarker for disease progression in AD, PD, ALS
Drug Development Targets
CXCR2 Antagonists: Block CXCL2 signaling to reduce neuroinflammation
Neutralizing Antibodies: Anti-CXCL2 antibodies to reduce levels
Small Molecule Inhibitors: Direct inhibitors of CXCL2 expressionResearch Directions
- Clinical trials of CXCR2 antagonists in ALS and AD
- Gene therapy approaches to modulate CXCL2 expression
- Combination therapies targeting multiple chemokines
Interactions
| Interactor | Type | Function |
|------------|------|----------|
| CXCR2 | Receptor | Primary signaling receptor |
| CXCR1 | Receptor | Secondary receptor |
| IL-8 | Chemokine | Related family member (CXCL8) |
| CXCL1 | Chemokine | Functional homolog |
| GM-CSF | Cytokine | Synergistic activation |
See Also
- [CXCL1 Gene](/genes/cxcl1) — Related chemokine
- [CXCR2](/entities/cxcr2) — Primary receptor
- [Neuroinflammation](/entities/neuroinflammation)
- [Microglia](/cell-types/microglia)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
External Links
- [NCBI Gene: CXCL2](https://www.ncbi.nlm.nih.gov/gene/2920)
- [UniProt: CXCL2](https://www.uniprot.org/uniprot/P19875)
- [OMIM: CXCL2](https://omim.org/entry/139387)
- [Ensembl: CXCL2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000024836)
- [GeneCards: CXCL2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL2)
References
[Brenchley JM, et al. CXCL2/MIP-2: a neutrophil attractant with pathogenic significance. Journal of Immunology (2006)](https://pubmed.ncbi.nlm.nih.gov/16622214/)
[Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity (2006)](https://pubmed.ncbi.nlm.nih.gov/16729981/)
[Raman D, et al. CXCL2 and its receptor CXCR2 in neurological diseases. Current Neurovascular Research (2011)](https://pubmed.ncbi.nlm.nih.gov/21964575/)
[O'Connor T, Bellinger DC. The role of chemokines in brain injury and disease. Brain Research Reviews (2005)](https://pubmed.ncbi.nlm.nih.gov/15658933/)
[Lee SC, et al. CXCL2 produced by activated microglia contributes to excitotoxic neuronal death. Glia (2008)](https://pubmed.ncbi.nlm.nih.gov/18805462/)
[Stadtmann A, Zarbock A. CXCR2 signaling and neutrophil recruitment. Cold Spring Harbor Perspectives in Biology (2015)](https://pubmed.ncbi.nlm.nih.gov/25585878/)
[Glass WG, et al. Chemokine mediated neurotoxicity in viral infections. Brain Research (2010)](https://pubmed.ncbi.nlm.nih.gov/20144998/)
[Liu J, et al. Targeting chemokines in amyotrophic lateral sclerosis. Neuropharmacology (2016)](https://pubmed.ncbi.nlm.nih.gov/27428049/)Pathway Diagram
The following diagram shows the key molecular relationships involving CXCL2 — C-X-C Motif Chemokine Ligand 2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)